SCHEMBL1833049

SCHEMBL1833049

C[C@H](CC1CCN(C(=O)OC(C)(C)C)CC1)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.50
PKM P14618 1/20 0.50
HPGD P15428 1/20 0.48
GPR119 Q8TDV5 5/20 0.46
RECQL P46063 1/20 0.46
EPHX1 P07099 1/20 0.46
NPC1 O15118 1/20 0.45
ALDH1A1 P00352 1/20 0.45
MAPT P10636 1/20 0.45
MAPK1 P28482 1/20 0.45
HTT P42858 1/20 0.45
RAB9A P51151 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
USP2 O75604 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
FAAH O00519 1/20 0.43
NR1H2 P55055 1/20 0.42
YAP1 P46937 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7497123 1.00 KDM4E (0.50) KDM4EPKMHPGDGPR119RECQL
SCHEMBL3654209 1.00 KDM4E (0.50) KDM4EPKMHPGDGPR119RECQL
SCHEMBL7353432 0.88 KDM4E (0.52) KDM4EPKMHPGDGPR119RECQL
SCHEMBL27796561 0.87 HPGD (0.50) KDM4EPKMHPGDGPR119RECQL
SCHEMBL20618515 0.87 HPGD (0.49) KDM4EPKMHPGDGPR119RECQL
SCHEMBL12061214 0.87 HPGD (0.49) KDM4EPKMHPGDGPR119RECQL
SCHEMBL5574062 0.87 KDM4E (0.51) KDM4EPKMHPGDGPR119RECQL
SCHEMBL104996 0.86 HPGD (0.51) KDM4EPKMHPGDGPR119RECQL
SCHEMBL595083 0.86 KDM4E (0.48) KDM4EPKMHPGDGPR119RECQL
Hydrochloric Acid SCHEMBL28354870 0.85 HPGD (0.48) KDM4EPKMHPGDGPR119RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4676927-A1 HETEROCYCLIC COMPOUNDS AS WRN INHIBITORS Synnovation Therapeutics, Inc. (US) 2026-01-14 EP disclosed
WO-2024187049-A1 HETEROCYCLIC COMPOUNDS AS WRN INHIBITORS SYNNOVATION THERAPEUTICS, INC. (US) 2024-09-12 WO disclosed
EP-2321305-A1 HETEROCYCLIC GPCR AGONISTS Prosidion Limited (GB) 2011-05-18 EP disclosed
EP-2321297-A1 PIPERIDINYL GPCR AGONISTS Prosidion Limited (GB) 2011-05-18 EP disclosed
WO-2010004343-A1 PIPERIDINYL GPCR AGONISTS PROSIDION LIMITED (GB) 2010-01-14 WO disclosed
WO-2010004348-A1 HETEROCYCLIC GPCR AGONISTS PROSIDION LIMITED (GB) 2010-01-14 WO disclosed
EP-2114932-A1 PIPERIDINE GPCR AGONISTS Prosidion Limited (GB) 2009-11-11 EP disclosed
EP-2114935-A1 PIPERIDINE GPCR AGONISTS Prosidion Limited (GB) 2009-11-11 EP disclosed
EP-2114933-A1 PIPERIDINE GPCR AGONISTS Prosidion Limited (GB) 2009-11-11 EP disclosed
EP-2114931-A1 PIPERIDINE GPCR AGONISTS Prosidion Limited (GB) 2009-11-11 EP disclosed
WO-2008081207-A1 PIPERIDINE GPCR AGONISTS PROSIDION LIMITED (GB) 2008-07-10 WO disclosed
WO-2008081206-A1 PIPERIDINE GPCR AGONISTS PROSIDION LIMITED (GB) 2008-07-10 WO disclosed
WO-2008081204-A1 PIPERIDINE GPCR AGONISTS PROSIDION LIMITED (GB) 2008-07-10 WO disclosed
WO-2008081205-A1 PIPERIDINE GPCR AGONISTS PROSIDION LIMITED (GB) 2008-07-10 WO disclosed